News Releases

December 16, 2020

Certara Announces Closing of Its Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

December 10, 2020

Certara Announces Pricing of Its Upsized Initial Public Offering

December 3, 2020

Certara Announces Launch of Initial Public Offering

November 9, 2020

Certara Opens New China Office in Shanghai

October 8, 2020

Certara Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

October 1, 2020

Food and Drug Administration Renews and Expands Use of Certara’s Biosimulation Software for Reviewing Regulatory Submissions

August 13, 2020

Certara Announces First Enrollee in International Registry to Assess Preventative Therapies in Healthcare Workers Exposed to COVID-19

August 10, 2020

Certara Announces New COVID-19 Biosimulation Platform and Key Updates to Its Quantitative Systems Pharmacology (QSP) Technology Platforms

July 23, 2020

Certara Launches COVID-19 Clinical Outcomes Database

June 26, 2020

Certara Launches Version 8.3 of Phoenix™ Biosimulation Software for Drug Development